Coastal Infusion Administers Opdivo®
| J-Code | J9299 |
|---|---|
| Manufacturer | Bristol-Myers Squibb |
| First Approved | 12/22/2014 |
Coastal Infusion can administer your Opdivo prescription at any of our south Florida locations.
Opdivo (nivolumab) is a cancer medication used in adults for various cancers. Opdivo is an immune checkpoint inhibitor, which helps the immune system fight cancer cells. Opdivo is used when cancers are advanced, unresectable, or metastatic, or when other treatments do not work.
The active substance in Opdivo, nivolumab, is a monoclonal antibody. Cancer cells can produce proteins (PD-L1 and PD-L2) on their surface that attach to the PD-1 receptor and switch off the activity of the T cells, preventing them from attacking the cancer. By attaching to the receptor, nivolumab prevents PD-L1 and PD-L2 from switching off the T cells, thereby increasing the ability of the immune system to kill cancer cells.
What It Treats
- Melanoma and cutaneous squamous cell carcinoma (cSCC)
- Hodgkin lymphoma
- Cervical cancer
- Non-small cell lung cancer (NSCLC)
- Squamous Esophageal cancers
- Head and neck cancers
- Other cancers
Prescribed By
Opdivo is most often prescribed by Oncologists, Hematologists, Urologists, Pulmonologists, Gastroenterologists, and others.
How it’s Administered
Opdivo is administered by intravenous infusion. Opdivo infusions take about 30 minutes.
Frequency
Opdivo is generally administered every two or four weeks.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies